Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict

• 作 者: Natsuki Ishida Takahiro Miyazu Satoshi Tamura Shinya Tani Mihoko Yamade Moriya Iwaizumi Yasushi Hamaya Satoshi Osawa Tak
• 机 构: FirstDepartmentofMedicine,DepartmentofLaboratoryMedicine,DepartmentofEndoscopicandPhotodynamicMedici
• 出 处: 世界胃肠病学杂志:英文版
• 发表日期: 2021年22期
• 关键词: Ulcerative colitis TACROLIMUS ALBUMIN

BACKGROUND Oral tacrolimus is a therapeutic agent for moderate to severe steroid-dependent or resistant ulcerative colitis(UC),but remission induction is difficult,and it is necessary to treat the patient while considering the next treatment.AIM To examin